magnolia obovata bark extract은 임신 중 안전한가요?
No EU Annex II/III listing, no harmonised CLP classification, no SCCS/CIR safety assessment located, and no reproductive/developmental toxicity data specific to Magnolia obovata bark extract were found in PubMed searches; cosmetics/topical use therefore has low but measurable dermal exposure (ingredient is an extract containing lipophilic lignans such as magnolol/honokiol which are bioactive). Sources searched include CosIng listings and PubMed studies showing pharmacology/toxicity work but not reproductive effects. (see sources)
Pregnancy-safe products containing magnolia obovata bark extract
Related ingredients
Frequently asked questions
- magnolia obovata bark extract은 임신 중 안전한가요?
- No EU Annex II/III listing, no harmonised CLP classification, no SCCS/CIR safety assessment located, and no reproductive/developmental toxicity data specific to Magnolia obovata bark extract were found in PubMed searches; cosmetics/topical use therefore has low but measurable dermal exposure (ingredient is an extract containing lipophilic lignans such as magnolol/honokiol which are bioactive). Sources searched include CosIng listings and PubMed studies showing pharmacology/toxicity work but not reproductive effects. (see sources)
- magnolia obovata bark extract은 모유 수유 중 안전한가요?
- Same evidence base as pregnancy: no regulatory bans or harmonised reproductive hazards found, no breastfeeding-specific data. Topical exposure is likely low but measurable; because active components are lipophilic, maternal dermal absorption could occur but no data show transfer into milk for this specific extract.
- magnolia obovata bark extract은 아기 피부에 안전한가요?
- No infant-specific safety studies found. Following your rules, exposure score is increased by +1 for babies because the ingredient is not completely non‑absorbable and contains lipophilic actives (magnolol/honokiol); therefore if adult exposure is 1, infant exposure is 2. No data were found showing increased hazard or mechanism specific to infants.
- VeriMom은 magnolia obovata bark extract을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 magnolia obovata bark extract을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 magnolia obovata bark extract 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.



